Login to Your Account



Other News To Note


Thursday, February 21, 2013
• Gilead Sciences Inc., of Foster City, Calif., said it reached an agreement in principle with Teva Pharmaceuticals Industries Ltd., of Jerusalem, settling litigation concerning the patents protecting Viread (tenofovir disoproxil fumarate), Gilead's treatment for HIV infection and chronic hepatitis B virus.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription